Publications
224 results found
LIGHTSTONE E, MARVEL J, MITCHISON A, 1992, MEMORY IN HELPER T-CELLS OF MINOR HISTOCOMPATIBILITY ANTIGENS, REVEALED INVIVO BY ALLOIMMUNIZATIONS IN COMBINATION WITH THY-1 ANTIGEN, EUROPEAN JOURNAL OF IMMUNOLOGY, Vol: 22, Pages: 115-122, ISSN: 0014-2980
- Author Web Link
- Cite
- Citations: 22
ELLIS J, CHAIN BM, DAVIES DH, et al., 1991, ANTIGEN PRESENTATION BY DENDRITIC CELLS PROVIDES OPTIMAL STIMULATION FOR THE PRODUCTION OF INTERLEUKIN (IL)2, IL4 AND INTERFERON-GAMMA BY ALLOGENEIC T-CELLS, EUROPEAN JOURNAL OF IMMUNOLOGY, Vol: 21, Pages: 2803-2809, ISSN: 0014-2980
- Author Web Link
- Cite
- Citations: 35
EZINE S, MARVEL J, LIGHTSTONE E, et al., 1991, CD45RA ANTIBODIES SPLIT THE CD3BRIGHT T-CELL SUBSET, INTERNATIONAL IMMUNOLOGY, Vol: 3, Pages: 917-922, ISSN: 0953-8178
- Author Web Link
- Cite
- Citations: 10
LIGHSTONE EB, WYLLIE D, MARVEL J, 1991, IN THE MOUSE THE MATURATION STAGE OF THE PERIPHERAL CD4+CD45RA+ SUBSET IS DIFFERENT FROM THAT OF THE CD8+CD45RA+ SUBSET, EUROPEAN JOURNAL OF IMMUNOLOGY, Vol: 21, Pages: 2161-2165, ISSN: 0014-2980
- Author Web Link
- Cite
- Citations: 12
LIGHTSTONE E, MARVEL J, 1991, MAINTENANCE OF EXPRESSION OF CD45RA ON MURINE SPLENOCYTES INVIVO, FASEB JOURNAL, Vol: 5, Pages: A1690-A1690, ISSN: 0892-6638
MARVEL J, LIGHTSTONE E, SAMBERG NL, et al., 1991, THE CD45RA MOLECULE IS EXPRESSED IN NAIVE MURINE CTL PRECURSORS BUT ABSENT IN MEMORY AND EFFECTOR CTL, INTERNATIONAL IMMUNOLOGY, Vol: 3, Pages: 21-28, ISSN: 0953-8178
- Author Web Link
- Cite
- Citations: 20
LIGHTSTONE EB, MARVEL J, 1990, CD45RA IS DETECTED IN ALL THYMOCYTE SUBSETS DEFINED BY CD4 AND CD8 BY USING 3-COLOR FLOW-CYTOMETRY, IMMUNOLOGY, Vol: 71, Pages: 467-472, ISSN: 0019-2805
- Author Web Link
- Cite
- Citations: 21
LIGHTSTONE E, MARVEL J, 1990, EXPRESSION OF CD45 ON T-CELL POPULATIONS, IMMUNOLOGY TODAY, Vol: 11, Pages: 432-432, ISSN: 0167-5699
MARVEL J, POIRIER G, LIGHTSTONE E, 1989, ANTI-CD45RA ANTIBODIES INCREASE THE PROLIFERATION OF MOUSE T-CELLS TO PHYTOHEMAGGLUTININ THROUGH THE INTERLEUKIN-2 INTERLEUKIN-2 RECEPTOR PATHWAY, EUROPEAN JOURNAL OF IMMUNOLOGY, Vol: 19, Pages: 2005-2010, ISSN: 0014-2980
- Author Web Link
- Cite
- Citations: 26
FISHER AG, GOFF LK, LIGHTSTONE L, et al., 1989, PROBLEMS IN THE PHYSIOLOGY OF CLASS-I AND CLASS-II MHC MOLECULES, AND OF CD45, 3RD SYMP ON IMMUNOLOGICAL RECOGNITION, Publisher: COLD SPRING HARBOR LABORATORY PRESS, Pages: 667-674
- Author Web Link
- Cite
- Citations: 9
Fisher AG, Goff LK, Lightstone L, et al., 1989, Problems in the physiology of class I and class II MHC molecules, and of CD45., Cold Spring Harb Symp Quant Biol, Vol: 54 Pt 2, Pages: 667-674, ISSN: 0091-7451
1. Co-processing of alloantigens suggests that epitope-loaded MHC class I molecules may pass from tissue cells to dendritic cells. 2. Antigen-presenting cells in the thymus need some special trick in order to load their MHC class II molecules with epitopes from "intermediate concentration" self-proteins in order to induce self-tolerance in developing cells. 3. Cell-cell interactions may transmit signals simply by rearranging surface glycoproteins and thus locally perturbing a phosphorylation equilibrium. 4. The CD45 and STB1 phenotype of most cells in the thymus may be characteristic of a doomed cell.
FISHER AG, GOFF LK, LIGHTSTONE L, et al., 1989, PROBLEMS IN THE PHYSIOLOGY OF CLASS-I AND CLASS-II MHC MOLECULES, AND OF CD45, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, Vol: 54, Pages: 667-674, ISSN: 0091-7451
- Author Web Link
- Cite
- Citations: 9
LIGHTSTONE BL, GREAVES WE, HUMPHRIES JM, 1988, COMPARISON OF MICTRAL WITH AMOXYCILLIN, TRIMETHOPRIM AND NITROFURANTOIN IN THE TREATMENT OF ACUTE CYSTITIS, BRITISH JOURNAL OF CLINICAL PRACTICE, Vol: 42, Pages: 283-288, ISSN: 0007-0947
- Author Web Link
- Cite
- Citations: 3
Lightstone E, 1988, Slides on renal medicine., Br J Hosp Med, Vol: 39, Pages: 450-452, ISSN: 0007-1064
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.